A study of 39 people with severe COVID-19 who received convalescent plasma found lower rates of mortality and and less need for oxygen supplementation after 14 days than in 156 similar patients who did not receive convalescent plasma. Researchers cautioned in the journal Nature Medicine that the study was not a randomized controlled trial and said more trials are needed.
Small study tests convalescent plasma for severe COVID-19
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.